The emerging treatment of this peptide represents a major advance in the handling of diabetes mellitus type 2. Unlike existing drugs, tirzepatide affects multiple pathways – glucagon-like peptide-1 (GLP-1) and the https://tirzepatide-peptide803376.suomiblog.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-57881289